BioTelemetry, Inc. (NASDAQ:BEAT) will be discussing 3Q20 financial results with the investment community.on 29th October 2020 at 5:00 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.gobio.com
Earnings Expectation
BioTelemetry, Inc. is reporting third quarter earnings results on Thursday 29th October 2020, after market close.
The consensus estimates from Thomson Reuters are income of $ 0.38 per share from $ 105.10 million in revenue. For the full year, analysts predict revenues of $ 434.35 million, while looking forward to income of $ 1.44 per share.
BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in Healthcare, Research, and Corporate and Other segments. The Healthcare segment focuses on the remote cardiac monitoring to identify arrhythmias or heart rhythm disorders.
